Viewing Study NCT06995833


Ignite Creation Date: 2025-12-25 @ 3:02 AM
Ignite Modification Date: 2025-12-31 @ 5:21 AM
Study NCT ID: NCT06995833
Status: RECRUITING
Last Update Posted: 2025-12-05
First Post: 2025-05-28
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Durvalumab With or Without Olaparib in Patients With Endometrial Cancers Regulatory Post Marketing Surveillance
Sponsor: AstraZeneca
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Outcomes Module Eligibility Module Contacts Locations Module